Welcome To The HIV Academy
Open Menu


Welcome to the Gilead HIV Academy Web-Portal. This Web-Portal has been designed to enable easy access for healthcare professionals to educational content and details about the HIV Academy and other upcoming educational events organised by Gilead.

Past meetings

Healthcare professionals will have access to educational content such as webcasts and lectures from past educational meetings.

Present meetings

Registered attendees will be able to engage with the experts via the Web-Portal through interactive voting and question panel submissions.

Future meetings

Healthcare professionals will have access to details about upcoming educational events and will have an opportunity to register their interest in attending.

We hope that you enjoy using this Web-Portal and find the content it contains useful and informative.

Sign in

Forgot details

New to this website?

If you are new to this website and have not registered, please click here to enter your details and begin the registration process.


About this website?

This site has been developed by Gilead Sciences Middle East for use by healthcare professionals to access educational content and register to upcoming educational events.

This web-portal is provided by Gilead as a professional service to the medical community. Information related to any product(s) may not be consistent with the local prescribing information. Please consult the full local prescribing information for approved information on any products discussed in this web-portal and before prescribing.
Reporting suspected adverse reactions after authorization of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable in your country.
Adverse reactions may also be reported directly to the manufacturer of the suspected product.
Adverse reactions related to Gilead products may be reported directly to Gilead via Drugsafety.dubai@gilead.com.
Please rotate your device and view this website in landscape